Spots Global Cancer Trial Database for stage ib pancreatic cancer

Every month we try and update this database with for stage ib pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study	NCT02345460	Pancreatic Aden... Poorly Differen... Resectable Panc... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Undifferentiate...	Irinotecan Hydr... Oxaliplatin Leucovorin Calc... Fluorouracil Laboratory Biom...	18 Years - 75 Years	Case Comprehensive Cancer Center
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery	NCT00305877	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	cetuximab gemcitabine hyd... capecitabine radiation thera... bevacizumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer	NCT01959672	Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con...	19 Years -	University of Nebraska
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy	NCT02414100	Pancreatic Duct... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre...	Laboratory Biom... Cytology Specim...	18 Years -	Thomas Jefferson University
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer	NCT02349867	Pancreatic Aden... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Recurrent Pancr...	Gemcitabine Sorafenib Vorinostat 3-Dimensional C... Intensity-Modul... RosetteSep DEPfff	18 Years -	Virginia Commonwealth University
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer	NCT01918644	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	stereotactic bo... capecitabine therapeutic con... magnetic resona... laboratory biom...	19 Years -	University of Wisconsin, Madison
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer	NCT01959672	Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con...	19 Years -	University of Nebraska
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery	NCT01416662	Pancreatic Canc...	gemcitabine hyd...	18 Years - 120 Years	Federation Francophone de Cancerologie Digestive
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer	NCT01959672	Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con...	19 Years -	University of Nebraska
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer	NCT01918644	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	stereotactic bo... capecitabine therapeutic con... magnetic resona... laboratory biom...	19 Years -	University of Wisconsin, Madison
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery	NCT00482625	Intraductal Pap... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	erlotinib hydro... conventional su... immunohistochem... protein express... biopsy pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery	NCT02511821	Stage I Adult L... Stage I Colorec... Stage IA Gastri... Stage IA Pancre... Stage IB Gastri... Stage IB Pancre... Stage II Adult ... Stage IIA Color... Stage IIA Gastr... Stage IIA Pancr... Stage IIB Color... Stage IIB Gastr... Stage IIB Pancr... Stage IIC Color... Stage III Pancr... Stage IIIA Adul... Stage IIIA Colo... Stage IIIA Gast... Stage IIIB Adul... Stage IIIB Colo... Stage IIIB Gast... Stage IIIC Adul... Stage IIIC Colo... Stage IIIC Gast... Stage IV Gastri... Stage IVA Color... Stage IVA Liver... Stage IVA Pancr... Stage IVB Color... Stage IVB Liver... Stage IVB Pancr...	Computer-Assist... Vivofit watch Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
Perioperative Therapy for Resectable Pancreatic Cancer	NCT00609336	Adenocarcinoma ... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	gemcitabine hyd... docetaxel capecitabine intensity-modul... oxaliplatin pancreatic surg... therapeutic con... laboratory biom...	18 Years -	University of Washington
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery	NCT00305877	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	cetuximab gemcitabine hyd... capecitabine radiation thera... bevacizumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer	NCT02349867	Pancreatic Aden... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Recurrent Pancr...	Gemcitabine Sorafenib Vorinostat 3-Dimensional C... Intensity-Modul... RosetteSep DEPfff	18 Years -	Virginia Commonwealth University
Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery	NCT01954732	Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	metformin hydro... pharmacological...	18 Years -	Case Comprehensive Cancer Center
Perioperative Therapy for Resectable Pancreatic Cancer	NCT00609336	Adenocarcinoma ... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr...	gemcitabine hyd... docetaxel capecitabine intensity-modul... oxaliplatin pancreatic surg... therapeutic con... laboratory biom...	18 Years -	University of Washington
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery	NCT01416662	Pancreatic Canc...	gemcitabine hyd...	18 Years - 120 Years	Federation Francophone de Cancerologie Digestive
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery	NCT00482625	Intraductal Pap... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	erlotinib hydro... conventional su... immunohistochem... protein express... biopsy pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: